Back to search

Article

Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus

2022-02-10

Abstract excerpt

<h4>Background: </h4> Four vaccines that have been authorized in the European Union offer different levels of protection against SARS-CoV-2 by generating immune responses against the spike receptor-binding domain (RBD) of the virus. Monitoring the levels of IgG antibodies against the SARS-CoV-2 is important during the coronavirus disease 2019 (COVID-19) pandemic to plan an adequate and evidence-based public health...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9712d36c-8e00-53cc-a5fa-4818386877ea
DOI
10.21203/rs.3.rs-1294394/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in CyprusDOI 10.21203/rs.3.rs-1294394/v1
Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccinationSemantic proximity
SARS-CoV-2 Infection, Vaccination and Antibody Response Trajectories in Adults: A Cohort Study in CataloniaSemantic proximity
Influencing factors of Anti-SARS-CoV-2-Spike IgG antibody titres in healthcare workers – A cross-section studySemantic proximity
Analysis of IgG, IgA, and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccinesSemantic proximity
Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titersSemantic proximity
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesSemantic proximity
Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variantsSemantic proximity
Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studySemantic proximity
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?Semantic proximity
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune ResponsesSemantic proximity
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domainSemantic proximity
Analysis of SARS-CoV-2 Ig seroprevalence in Northern IrelandSemantic proximity
Select a neighboring publication to make it the new centre.